Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1ACE-083----[2] 10, 113 💬
2Acido ascorbico----[1] 10 💬
3Ascorbic acid[1] Ascorbic acid[1] Ascorbic acid 💬 --[4] 10, 97, 206, 298 💬
4Baclofen[1] Baclofen[1] Baclofen 💬 [2] GABBR,
GABBR 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[7] 2, 10, 13, 18, 65, 149, 206 💬
5Baclofene----[1] 10 💬
6Cebion 500*20CPR mast 500MG----[1] 10 💬
7Cebion 500MG 20CPR mast.aran----[1] 10 💬
8CLZ-2002[1] CLZ-2002---[1] 10 💬
9Coenzyme Q10[1] Ubidecarenone[1] Ubidecarenone 💬 --[12] 2, 5, 6, 8, 10, 46, 57, 107, 113, 193, 214, 215 💬
10D-biotin----[3] 10, 13, 20 💬
11D-sorbitol[1] Sorbitol[1] Sorbitol solution 💬 --[1] 10 💬
12Elleone----[1] 10 💬
13EN001----[2] 10, 113 💬
14Engensis[1] Engensis---[2] 2, 10 💬
15Epalrestat[1] Epalrestat[1] Epalrestat 💬 [1] AKR1B 💬 [5] Folate biosynthesis, Fructose and mannose metabolism, Galactose metabolism, Glycerolipid metabolism, Pentose and glucuronate interconversions 💬[1] 10 💬
16MD1003----[5] 2, 10, 13, 14, 20 💬
17Mexiletine[1] Mexiletine[2] Mexiletine hydrochloride ,
Mexiletine 💬 		[5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[4] 2, 10, 113, 114 💬
18Naltrexone[1] Naltrexone[2] Naltrexone hydrochloride ,
Naltrexone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[5] 6, 10, 13, 96, 226 💬
19Naltrexone cloridrato[1] Naltrexone[2] Naltrexone hydrochloride ,
Naltrexone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 10 💬
20Naltrexone hydrochloride[1] Naltrexone[2] Naltrexone hydrochloride ,
Naltrexone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[9] 10, 40, 41, 42, 43, 44, 45, 96, 97 💬
21NMD670----[3] 3, 10, 11 💬
22NON applicable----[2] 10, 19 💬
23Posturological examination ON kplates and amti platforms----[1] 10 💬
24PXT3003----[1] 10 💬
25PXT3003 dose 1----[1] 10 💬
26PXT3003 dose 2----[1] 10 💬
27PXT3003 high dose----[1] 10 💬
28PXT3003 intermediate dose----[1] 10 💬
29PXT3003 LOW dose----[1] 10 💬
30RS-baclofen----[1] 10 💬
31Sorbitol[1] Sorbitol[1] Sorbitol solution 💬 --[1] 10 💬
32Sorbitolo----[1] 10 💬
33Ulipristal acetate[1] Ulipristal[2] Ulipristal ,
Ulipristal acetate 💬 		[1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 10 💬
34Vitamin C[1] Ascorbic acid[1] Ascorbic acid 💬 --[6] 10, 192, 206, 210, 211, 212 💬